ARELY VALDEZ PEREZ: Open Payments
NPI 1477221471 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 57 payments from 14 companies in 2025. Trend: 2023 $668 · 2024 $1,013 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $223 |
| AstraZeneca Pharmaceuticals LP | 9 | $222 |
| Novo Nordisk Inc | 12 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| PFIZER INC. | 4 | $69 |
| Lilly USA, LLC | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Amgen Inc. | 4 | $60 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Organon LLC | 1 | $20 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, BYETTA, Ozempic, Rybelsus, QULIPTA, ROTATEQ.
Industry payments across AZ — which companies pay providers there.
